ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 117 filers reported holding ANI PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | – | 0 | – | 0.00% | – |
Q4 2020 | $0 | – | 0 | – | 0.00% | – |
Q3 2020 | $0 | – | 0 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q4 2019 | $3,000 | 0.0% | 54 | +14.9% | 0.00% | – |
Q3 2019 | $3,000 | 0.0% | 47 | -37.3% | 0.00% | – |
Q4 2018 | $3,000 | -50.0% | 75 | -24.2% | 0.00% | – |
Q3 2018 | $6,000 | +20.0% | 99 | +20.7% | 0.00% | – |
Q2 2018 | $5,000 | -37.5% | 82 | -34.4% | 0.00% | – |
Q1 2018 | $8,000 | 0.0% | 125 | 0.0% | 0.00% | – |
Q4 2017 | $8,000 | 0.0% | 125 | -17.2% | 0.00% | – |
Q3 2017 | $8,000 | +14.3% | 151 | 0.0% | 0.00% | – |
Q2 2017 | $7,000 | 0.0% | 151 | +11.9% | 0.00% | – |
Q1 2017 | $7,000 | 0.0% | 135 | +15.4% | 0.00% | – |
Q4 2016 | $7,000 | -12.5% | 117 | 0.0% | 0.00% | – |
Q3 2016 | $8,000 | +700.0% | 117 | +588.2% | 0.00% | – |
Q2 2016 | $1,000 | 0.0% | 17 | 0.0% | 0.00% | – |
Q4 2015 | $1,000 | – | 17 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |